HIGHFDA DRUG

Westminster Pharmaceuticals Metoprolol Tartrate 50 mg Recall Over Nitrosamine Above ADI Level (2025)

Westminster Pharmaceuticals recalls 16,672 boxes of Metoprolol Tartrate 50 mg tablets nationwide after nitrosamine exceeds Acceptable Daily Intake. Manufactured by Renata PLC in Bangladesh and distributed in the US by Westminster Pharmaceuticals. Consumers should stop using the product and contact their healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 6, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 6, 2025
Hazard Level
HIGH
Brands
METOPROLOL TARTRATE, Westminster Pharmaceuticals
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, ELDERLY

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
METOPROLOL TARTRATE, Westminster Pharmaceuticals
Product type
Metoprolol Tartrate Tablets
Model numbers
Batch # R55230021, Batch # R55230031, Batch # R55230041, Batch # R55230051, Batch # R55230061, Batch # R55230071, Batch # R55230081, Batch # R55230091 +8 more
UPC codes
69367-354, 69367-355, 69367-354-10, 69367-354-01, 69367-355-10, 69367-355-01
Sizes
1000-count bottles
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 6, 2025

  2. Reported by FDA DRUG

    August 20, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Westminster Pharmaceuticals LLC or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

About This Product

Metoprolol tartrate is a beta-blocker used to treat high blood pressure and other heart-related conditions. It is prescribed and distributed as a generic medication.

Why This Is Dangerous

Nitrosamines are potential carcinogens. Exceeding ADI implies potential long-term cancer risk with prolonged exposure.

Real-World Impact

The recall affects patients relying on these tablets for cardiovascular conditions. It requires immediate termination of use and medical consultation for alternatives.

Practical Guidance

How to identify if yours is affected

  1. Confirm 50 mg strength and 1000-count bottle.

Where to find product info

NDC 69367-354-10 on label; batch number on bottle label.

What timeline to expect

Refunds or replacements typically take 4-8 weeks after verification.

If the manufacturer is unresponsive

  • Document all contact attempts.
  • Escalate to FDA or consumer protection offices if manufacturer remains unresponsive.

How to prevent similar issues

  • For future drug recalls, monitor FDA recall notices and verify NDC and batch numbers before taking medications.
  • Ask pharmacists for lot-specific safety updates.
  • Be mindful of nitrosamine recalls in other medications.

Documentation advice

Keep all recall notices, bottle labels, batch numbers, and communications with pharmacy or provider. Save receipts and timelines.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Metoprolol Tartrate Tablets, USP, 50 mg, 1000-count bottles. Manufactured by Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh. Distributed by Westminster Pharmaceuticals, LLC, Nashville, TN 37217. NDC 69367-354-10. Batch numbers include R55230021 through R55230151 and R55240011, R55240021. Quantity recalled: 16,672 bottles. Sold nationwide in the USA.

Reported Incidents

No injuries or incidents have been reported in the provided data.

Key Facts

  • 16,672 1000-count bottles recalled
  • N-nitroso-metoprolol exceeds ADI
  • Nationwide distribution in the USA

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTELDERLYPREGNANTPREGNANTPREGNANT
Injury Types
POISONINGOTHER

Product Details

Model Numbers
Batch # R55230021
Batch # R55230031
Batch # R55230041
Batch # R55230051
Batch # R55230061
+11 more
UPC Codes
69367-354
69367-355
69367-354-10
+3 more
Affected States
ALL
Report Date
August 20, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more